News
A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...
Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback